Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies, 45733-45735 [05-15693]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 151 / Monday, August 8, 2005 / Notices
437. Daniel Bornhorst, Albany, New
York, Court of Federal Claims Number
05–0390V.
438. Lee Ann Kay on behalf of Mason
Kay, Boston, Massachusetts, Court of
Federal Claims Number 05–0393V.
439. Wendy Bengtson on behalf of
Brian Bengston, Boston, Massachusetts,
Court of Federal Claims Number 05–
0394V.
440. Rebecca Jackson, Fresno,
California, Court of Federal Claims
Number 05–0395V.
441. Debra Comer on behalf of Jacob
Eli Malcom, Port Washington, New
York, Court of Federal Claims Number
05–0398V.
442. Wendy Kumar and Kishore
Gosein on behalf of Daryl Gosein,
Somers Point, New Jersey, Court of
Federal Claims Number 05–0401V.
443. Eileen and John Regan on behalf
of Sean Regan, New York, New York,
Court of Federal Claims Number 05–
0402V.
444. Leah Soifer on behalf of Aharon
Soifer, Baltimore, Maryland, Court of
Federal Claims Number 05–0404V.
445. Maureen and Kenneth Murrah on
behalf of MacLain Murrah, Jacksonville,
Florida, Court of Federal Claims
Number 05–0407V.
446. Maria and Dean Lakis on behalf
of Lynn Lakis, Port Washington, New
York, Court of Federal Claims Number
05–0408V.
447. Kathryn and Robert Dorran on
behalf of Henry Dorran, Maryville,
Texas, Court of Federal Claims Number
05–0409V.
448. Colleen Papa on behalf of
Alexander Papa, Boston, Massachusetts,
Court of Federal Claims Number 05–
0412V.
449. Kathleen Kong on behalf of
Leialani Kong, Wailuku, Hawaii, Court
of Federal Claims Number 05–0414V.
450. Kay Benson, Boston,
Massachusetts, Court of Federal Claims
Number 05–0415V.
451. Kathy Edwards on behalf of
Joslyn Edwards, Joliet, Illinois, Court of
Federal Claims Number 05–0416V.
452. Lisa Ross on behalf of Shannon
Ross, Wilmington, North Carolina, Court
of Federal Claims Number 05–0417V.
453. Jennifer Morse, Boston,
Massachusetts, Court of Federal Claims
Number 05–0418V.
454. Susan Clark, Boston,
Massachusetts, Court of Federal Claims
Number 05–0419V.
455. Kelly Boley, Boston,
Massachusetts, Court of Federal Claims
Number 05–0420V.
456. Roberta Boullion, Boston,
Massachusetts, Court of Federal Claims
Number 05–0421V.
VerDate jul<14>2003
20:13 Aug 05, 2005
Jkt 205001
Dated: August 1, 2005.
Elizabeth M. Duke,
Administrator.
[FR Doc. 05–15613 Filed 8–5–05; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://workplace.samhsa.gov
and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs,
SAMHSA/CSAP, Room 2–1035, 1 Choke
Cherry Road, Rockville, Maryland
20857; 240–276–2600 (voice), 240–276–
2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Pub. L. 100–
71. Subpart C of the Mandatory
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
45733
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227, 414–328–
7840/800–877–7016, (Formerly:
Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118, 901–794–5770/888–290–
1150.
Aegis Analytical Laboratories, Inc., 345
Hill Ave., Nashville, TN 37210, 615–
255–2400.
Baptist Medical Center-Toxicology
Laboratory, 9601 I–630, Exit 7, Little
Rock, AR 72205–7299, 501–202–2783,
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira
Road, Lenexa, KS 66215–2802, 800–
445–6917.
Diagnostic Services, Inc., dba DSI,
12700 Westlinks Drive, Fort Myers,
FL 33913, 239–561–8200/800–735–
5416.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602, 229–671–
2281.
DrugScan, Inc., P.O. Box 2969, 1119
Mearns Road, Warminster, PA 18974,
215–674–9310.
Dynacare Kasper Medical Laboratories*,
10150–102 St., Suite 200, Edmonton,
Alberta, Canada T5J 5E2, 780–451–
3702/800–661–9876.
ElSohly Laboratories, Inc., 5 Industrial
Park Drive, Oxford, MS 38655, 662–
236–2609.
Express Analytical Labs, 3405 7th Ave.,
Suite 106, Marion, IA 52302, 319–
377–0500.
E:\FR\FM\08AUN1.SGM
08AUN1
45734
Federal Register / Vol. 70, No. 151 / Monday, August 8, 2005 / Notices
Gamma-Dynacare Medical
Laboratories*, A Division of the
Gamma-Dynacare, Laboratory
Partnership, 245 Pall Mall Street,
London, ONT, Canada N6A 1P4, 519–
679–1630.
General Medical Laboratories, 36 South
Brooks St., Madison, WI 53715, 608–
267–6225.
Kroll Laboratory Specialists, Inc., 1111
Newton St., Gretna, LA 70053, 504–
361–8989 / 800–433–3823 (Formerly:
Laboratory Specialists, Inc.).
LabOne, Inc., 10101 Renner Blvd.,
Lenexa, KS 66219, 913–888–3927 /
800–873–8845 (Formerly: Center for
Laboratory Services, a Division of
LabOne, Inc.).
Laboratory Corporation of America
Holdings, 7207 N. Gessner Road,
Houston, TX 77040, 713–856–8288 /
800–800–2387.
Laboratory Corporation of America
Holdings, 69 First Ave., Raritan, NJ
08869, 908–526–2400 / 800–437–4986
(Formerly: Roche Biomedical
Laboratories, Inc.).
Laboratory Corporation of America
Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709,
919–572–6900 / 800–833–3984
(Formerly: LabCorp Occupational
Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem
Laboratories, Inc., A Subsidiary of
Roche Biomedical Laboratory; Roche
CompuChem Laboratories, Inc., A
Member of the Roche Group).
Laboratory Corporation of America
Holdings, 10788 Roselle St., San
Diego, CA 92121, 800–882–7272
(Formerly: Poisonlab, Inc.)
Laboratory Corporation of America
Holdings, 550 17th Ave., Suite 300,
Seattle, WA 98122, 206–923–7020 /
800–898–0180 (Formerly: DrugProof,
Division of Dynacare/Laboratory of
Pathology, LLC; Laboratory of
Pathology of Seattle, Inc.; DrugProof,
Division of Laboratory of Pathology of
Seattle, Inc.).
Laboratory Corporation of America
Holdings, 1120 Main Street,
Southaven, MS 38671, 866–827–8042
/ 800–233–6339 (Formerly: LabCorp
Occupational Testing Services, Inc.;
MedExpress/National Laboratory
Center).
Marshfield Laboratories, Forensic
Toxicology Laboratory, 1000 North
Oak Ave., Marshfield, WI 54449, 715–
389–3734 / 800–331–3734.
MAXXAM Analytics Inc.,* 6740
Campobello Road, Mississauga, ON,
Canada L5N 2L8, 905–817–5700
(Formerly: NOVAMANN (Ontario),
Inc.).
VerDate jul<14>2003
20:13 Aug 05, 2005
Jkt 205001
MedTox Laboratories, Inc., 402 W.
County Road D, St. Paul, MN 55112,
651–636–7466 / 800–832–3244.
MetroLab-Legacy Laboratory Services,
1225 NE 2nd Ave., Portland, OR
97232, 503–413–5295 / 800–950–
5295.
Minneapolis Veterans Affairs Medical
Center, Forensic Toxicology
Laboratory, 1 Veterans Drive,
Minneapolis, MN 55417, 612–725–
2088.
National Toxicology Laboratories, Inc.,
1100 California Ave., Bakersfield, CA
93304, 661–322–4250 / 800–350–
3515.
Northwest Toxicology, a LabOne
Company, 2282 South Presidents
Drive, Suite C, West Valley City, UT
84120, 801–606–6301 / 800–322–3361
(Formerly: LabOne, Inc., dba
Northwest Toxicology; NWT Drug
Testing, NorthWest Toxicology, Inc.;
Northwest Drug Testing, a division of
NWT Inc.).
One Source Toxicology Laboratory, Inc.,
1213 Genoa-Red Bluff, Pasadena, TX
77504, 888–747–3774 (Formerly:
University of Texas Medical Branch,
Clinical Chemistry Division; UTMB
Pathology-Toxicology Laboratory).
Oregon Medical Laboratories, P.O. Box
972, 722 East 11th Ave., Eugene, OR
97440–0972, 541–687–2134.
Pacific Toxicology Laboratories, 9348
DeSoto Ave., Chatsworth, CA 91311,
800–328–6942 (Formerly: Centinela
Hospital Airport Toxicology
Laboratory).
Pathology Associates Medical
Laboratories, 110 West Cliff Dr.,
Spokane, WA 99204, 509–755–8991 /
800–541–7897x7.
Physicians Reference Laboratory, 7800
West 110th St., Overland Park, KS
66210, 913–339–0372 / 800–821–
3627.
Quest Diagnostics Incorporated, 3175
Presidential Dr., Atlanta, GA 30340,
770–452–1590 / 800–729–6432
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated, 4770
Regent Blvd., Irving, TX 75063, 800–
824–6152 (Moved from the Dallas
location on 03/31/01; Formerly:
SmithKline Beecham Clinical
Laboratories; SmithKline Bio-Science
Laboratories).
Quest Diagnostics Incorporated, 4230
South Burnham Ave., Suite 250, Las
Vegas, NV 89119–5412, 702–733–
7866 / 800–433–2750, (Formerly:
Associated Pathologists Laboratories,
Inc.).
Quest Diagnostics Incorporated, 400
Egypt Road, Norristown, PA 19403,
610–631–4600 / 877–642–2216,
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
(Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline BioScience Laboratories).
Quest Diagnostics Incorporated, 506 E.
State Pkwy., Schaumburg, IL 60173,
800–669–6995 / 847–885–2010,
(Formerly: SmithKline Beecham
Clinical Laboratories; International
Toxicology Laboratories).
Quest Diagnostics Incorporated, 7600
Tyrone Ave., Van Nuys, CA 91405,
818–989–2520 / 800–877–2520,
(Formerly: SmithKline Beecham
Clinical Laboratories).
Scientific Testing Laboratories, Inc., 450
Southlake Blvd., Richmond, VA
23236, 804–378–9130.
Sciteck Clinical Laboratories, Inc., 317
Rutledge Road, Fletcher, NC 28732,
828–650–0409.
S.E.D. Medical Laboratories, 5601 Office
Blvd., Albuquerque, NM 87109, 505–
727–6300 / 800–999–5227.
South Bend Medical Foundation, Inc.,
530 N. Lafayette Blvd., South Bend,
IN 46601, 574–234–4176 x276.
Southwest Laboratories, 4645 E. Cotton
Center Boulevard, Suite 177, Phoenix,
AZ 85040, 602–438–8507 / 800–279–
0027.
Sparrow Health System, Toxicology
Testing Center, St. Lawrence Campus,
1210 W. Saginaw, Lansing, MI 48915,
517–364–7400, (Formerly: St.
Lawrence Hospital & Healthcare
System).
St. Anthony Hospital Toxicology
Laboratory, 1000 N. Lee St.,
Oklahoma City, OK 73101, 405–272–
7052.
Toxicology & Drug Monitoring
Laboratory, University of Missouri
Hospital & Clinics, 301 Business Loop
70 West, Suite 208, Columbia, MO
65203, 573–882–1273.
Toxicology Testing Service, Inc., 5426
N.W. 79th Ave., Miami, FL 33166,
305–593–2260.
US Army Forensic Toxicology Drug
Testing Laboratory, 2490 Wilson St.,
Fort George G. Meade, MD 20755–
5235, 301–677–7085.
*The Standards Council of Canada (SCC)
voted to end its Laboratory Accreditation
Program for Substance Abuse (LAPSA)
effective May 12, 1998. Laboratories certified
through that program were accredited to
conduct forensic urine drug testing as
required by U.S. Department of
Transportation (DOT) regulations. As of that
date, the certification of those accredited
Canadian laboratories will continue under
DOT authority. The responsibility for
conducting quarterly performance testing
plus periodic on-site inspections of those
LAPSA-accredited laboratories was
transferred to the U.S. HHS, with the HHS’
NLCP contractor continuing to have an active
role in the performance testing and
laboratory inspection processes. Other
E:\FR\FM\08AUN1.SGM
08AUN1
Federal Register / Vol. 70, No. 151 / Monday, August 8, 2005 / Notices
Canadian laboratories wishing to be
considered for the NLCP may apply directly
to the NLCP contractor just as U.S.
laboratories do.
Upon finding a Canadian laboratory to be
qualified, HHS will recommend that DOT
certify the laboratory (Federal Register, July
16, 1996) as meeting the minimum standards
of the Mandatory Guidelines published in the
Federal Register on April 13, 2004 (69 FR
19644). After receiving DOT certification, the
laboratory will be included in the monthly
list of HHS-certified laboratories and
participate in the NLCP certification
maintenance program.
Anna Marsh,
Executive Officer, SAMHSA.
[FR Doc. 05–15693 Filed 8–5–05; 8:45 am]
BILLING CODE 4160–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[USCG–2005–21992]
Merchant Marine Personnel Advisory
Committee
Coast Guard, DHS.
Notice of meetings.
AGENCY:
ACTION:
SUMMARY: The Merchant Marine
Personnel Advisory Committee
(MERPAC) and its working groups will
meet to discuss various issues relating
to the training and fitness of merchant
marine personnel. MERPAC advises the
Secretary of Homeland Security on
matters relating to the training,
qualifications, licensing, and
certification of seamen serving in the
U.S. merchant marine. All meetings will
be open to the public.
DATES: MERPAC will meet on
Wednesday, September 7, 2005, from
8:30 a.m. to 4:30 p.m. and on Thursday,
September 8, 2005, from 8:30 a.m. to 4
p.m. These meetings may adjourn early
if all business is finished. Requests to
make oral presentations should reach
the Coast Guard on or before August 24,
2005. Written material and requests to
have a copy of your material distributed
to each member of the committee or
subcommittee should reach the Coast
Guard on or before August 24, 2005.
ADDRESSES: MERPAC will meet on both
days at the RTM STAR Center, 2 West
Dixie Highway, Dania Beach, FL 33004.
Further directions regarding the location
of the RTM STAR Center may be
obtained by contacting Ms. Vickie
Valderrama at (954) 920–3222,
extension 7253. Send written material
and requests to make oral presentations
to Mr. Mark Gould, Commandant (G–
MSO–1), U.S. Coast Guard
VerDate jul<14>2003
20:13 Aug 05, 2005
Jkt 205001
Headquarters, 2100 Second Street SW.,
Washington, DC 20593–0001. This
notice is available on the Internet at
https://dms.dot.gov.
FOR FURTHER INFORMATION CONTACT: For
questions on this notice, contact Mr.
Gould, Assistant to the Executive
Director, telephone 202–267–6890, fax
202–267–4570, or e-mail
mgould@comdt.uscg.mil.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is given under the
Federal Advisory Committee Act, 5
U.S.C. App. 2 (Pub. L. 92–463, 86 Stat.
770, as amended).
Agenda of Meeting on September 7,
2005:
The full committee will meet to
discuss the objectives for the meeting.
The working groups addressing the
following task statements may meet to
deliberate: Task Statement 30,
concerning utilizing military sea service
for STCW certifications; Task Statement
49, concerning recommendations for use
of a model sea course project in
conjunction with an approved program
for officer in charge of an engineering
watch coming up through the hawse
pipe; Task Statement 50, concerning
recommendations on a training and
assessment program for qualified
member of the engine department on
sea-going vessels; and Task Statement
51, concerning minimum standard of
competence on tanker safety. In
addition, new working groups may be
formed to address issues proposed by
the Coast Guard, MERPAC members, or
the public. All task statements may be
viewed at the MERPAC Web site at
https://www.uscg.mil/hq/g-m/advisory/
merpac/merpac.htm.
At the end of the day, the working
groups will make a report to the full
committee on what has been
accomplished in their meetings. No
action will be taken on these reports on
this date.
Agenda of Meeting on September 8,
2005:
The agenda comprises the following:
(1) Introduction.
(2) Working Groups’ Reports
(a) Task Statement 30, concerning
utilizing military sea service for STCW
certifications;
(b) Task Statement 49, concerning
recommendations for use of a model sea
course project in conjunction with an
approved program for officer in charge
of an engineering watch coming up
through the hawse pipe;
(c) Task Statement 50, concerning
recommendations on a training and
assessment program for qualified
member of the engine department on
sea-going vessels;
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
45735
(d) Task Statement 51, concerning
minimum standard of competence on
tanker safety; and
(e) Other task statements which may
have been adopted for discussion and
action.
(3) Other items to be discussed:
(a) Standing Committee—Prevention
Through People.
(b) Briefings concerning on-going
projects of interest to MERPAC.
(c) Other items brought up for
discussion by the committee or the
public.
Procedural:
Both meetings are open to the public.
Please note that the meetings may
adjourn early if all business is finished.
At the Chair’s discretion, members of
the public may make oral presentations
during the meetings. If you would like
to make an oral presentation at a
meeting, please notify Mr. Gould no
later than August 24, 2005. Written
material for distribution at a meeting
should reach the Coast Guard no later
than August 24, 2005. If you would like
a copy of your material distributed to
each member of the committee or
subcommittee in advance of the
meeting, please submit 25 copies to Mr.
Gould no later than August 24, 2005.
Information on Services for Individuals
with Disabilities
For information on facilities or
services for individuals with disabilities
or to request special assistance at the
meetings, contact Mr. Gould as soon as
possible.
Dated: July 27, 2005.
Captain Lorne W. Thomas, USCG,
Acting Director of Standards, Marine Safety,
Security and Environmental Protection.
[FR Doc. 05–15615 Filed 8–5–05; 8:45 am]
BILLING CODE 4910–15–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[CGD05–05–088]
Re-opening of South Berth at
Dominion Cove Point Liquefied Natural
Gas Facility, Calvert County, MD
Coast Guard, DHS.
Notice; request for public
comments.
AGENCY:
ACTION:
SUMMARY: The Coast Guard announces
the review of a request from Dominion
Cove Point Liquefied Natural Gas (LNG)
Limited Partnership to begin using the
south berth of its facility for receiving
LNG vessels. The Coast Guard solicits
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 70, Number 151 (Monday, August 8, 2005)]
[Notices]
[Pages 45733-45735]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15693]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Current List of Laboratories Which Meet Minimum Standards To
Engage in Urine Drug Testing for Federal Agencies
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) notifies
Federal agencies of the laboratories currently certified to meet the
standards of Subpart C of the Mandatory Guidelines for Federal
Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory
Guidelines were first published in the Federal Register on April 11,
1988 (53 FR 11970), and subsequently revised in the Federal Register on
June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on
April 13, 2004 (69 FR 19644).
A notice listing all currently certified laboratories is published
in the Federal Register during the first week of each month. If any
laboratory's certification is suspended or revoked, the laboratory will
be omitted from subsequent lists until such time as it is restored to
full certification under the Mandatory Guidelines.
If any laboratory has withdrawn from the HHS National Laboratory
Certification Program (NLCP) during the past month, it will be listed
at the end, and will be omitted from the monthly listing thereafter.
This notice is also available on the Internet at https://
workplace.samhsa.gov and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs, SAMHSA/CSAP, Room 2-1035, 1 Choke
Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-
2610 (fax).
SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in
accordance with Executive Order 12564 and section 503 of Pub. L. 100-
71. Subpart C of the Mandatory Guidelines, ``Certification of
Laboratories Engaged in Urine Drug Testing for Federal Agencies,'' sets
strict standards that laboratories must meet in order to conduct drug
and specimen validity tests on urine specimens for Federal agencies. To
become certified, an applicant laboratory must undergo three rounds of
performance testing plus an on-site inspection. To maintain that
certification, a laboratory must participate in a quarterly performance
testing program plus undergo periodic, on-site inspections.
Laboratories which claim to be in the applicant stage of
certification are not to be considered as meeting the minimum
requirements described in the HHS Mandatory Guidelines. A laboratory
must have its letter of certification from HHS/SAMHSA (formerly: HHS/
NIDA) which attests that it has met minimum standards.
In accordance with Subpart C of the Mandatory Guidelines dated
April 13, 2004 (69 FR 19644), the following laboratories meet the
minimum standards to conduct drug and specimen validity tests on urine
specimens:
ACL Laboratories, 8901 W. Lincoln Ave., West Allis, WI 53227, 414-328-
7840/800-877-7016, (Formerly: Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624,
585-429-2264.
Advanced Toxicology Network, 3560 Air Center Cove, Suite 101, Memphis,
TN 38118, 901-794-5770/888-290-1150.
Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN
37210, 615-255-2400.
Baptist Medical Center-Toxicology Laboratory, 9601 I-630, Exit 7,
Little Rock, AR 72205-7299, 501-202-2783, (Formerly: Forensic
Toxicology Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802, 800-
445-6917.
Diagnostic Services, Inc., dba DSI, 12700 Westlinks Drive, Fort Myers,
FL 33913, 239-561-8200/800-735-5416.
Doctors Laboratory, Inc., 2906 Julia Drive, Valdosta, GA 31602, 229-
671-2281.
DrugScan, Inc., P.O. Box 2969, 1119 Mearns Road, Warminster, PA 18974,
215-674-9310.
Dynacare Kasper Medical Laboratories*, 10150-102 St., Suite 200,
Edmonton, Alberta, Canada T5J 5E2, 780-451-3702/800-661-9876.
ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655,
662-236-2609.
Express Analytical Labs, 3405 7th Ave., Suite 106, Marion, IA 52302,
319-377-0500.
[[Page 45734]]
Gamma-Dynacare Medical Laboratories*, A Division of the Gamma-Dynacare,
Laboratory Partnership, 245 Pall Mall Street, London, ONT, Canada N6A
1P4, 519-679-1630.
General Medical Laboratories, 36 South Brooks St., Madison, WI 53715,
608-267-6225.
Kroll Laboratory Specialists, Inc., 1111 Newton St., Gretna, LA 70053,
504-361-8989 / 800-433-3823 (Formerly: Laboratory Specialists, Inc.).
LabOne, Inc., 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927 / 800-
873-8845 (Formerly: Center for Laboratory Services, a Division of
LabOne, Inc.).
Laboratory Corporation of America Holdings, 7207 N. Gessner Road,
Houston, TX 77040, 713-856-8288 / 800-800-2387.
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ
08869, 908-526-2400 / 800-437-4986 (Formerly: Roche Biomedical
Laboratories, Inc.).
Laboratory Corporation of America Holdings, 1904 Alexander Drive,
Research Triangle Park, NC 27709, 919-572-6900 / 800-833-3984
(Formerly: LabCorp Occupational Testing Services, Inc., CompuChem
Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche
Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of
the Roche Group).
Laboratory Corporation of America Holdings, 10788 Roselle St., San
Diego, CA 92121, 800-882-7272 (Formerly: Poisonlab, Inc.)
Laboratory Corporation of America Holdings, 550 17th Ave., Suite 300,
Seattle, WA 98122, 206-923-7020 / 800-898-0180 (Formerly: DrugProof,
Division of Dynacare/Laboratory of Pathology, LLC; Laboratory of
Pathology of Seattle, Inc.; DrugProof, Division of Laboratory of
Pathology of Seattle, Inc.).
Laboratory Corporation of America Holdings, 1120 Main Street,
Southaven, MS 38671, 866-827-8042 / 800-233-6339 (Formerly: LabCorp
Occupational Testing Services, Inc.; MedExpress/National Laboratory
Center).
Marshfield Laboratories, Forensic Toxicology Laboratory, 1000 North Oak
Ave., Marshfield, WI 54449, 715-389-3734 / 800-331-3734.
MAXXAM Analytics Inc.,* 6740 Campobello Road, Mississauga, ON, Canada
L5N 2L8, 905-817-5700 (Formerly: NOVAMANN (Ontario), Inc.).
MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112,
651-636-7466 / 800-832-3244.
MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR
97232, 503-413-5295 / 800-950-5295.
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088.
National Toxicology Laboratories, Inc., 1100 California Ave.,
Bakersfield, CA 93304, 661-322-4250 / 800-350-3515.
Northwest Toxicology, a LabOne Company, 2282 South Presidents Drive,
Suite C, West Valley City, UT 84120, 801-606-6301 / 800-322-3361
(Formerly: LabOne, Inc., dba Northwest Toxicology; NWT Drug Testing,
NorthWest Toxicology, Inc.; Northwest Drug Testing, a division of NWT
Inc.).
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena,
TX 77504, 888-747-3774 (Formerly: University of Texas Medical Branch,
Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory).
Oregon Medical Laboratories, P.O. Box 972, 722 East 11th Ave., Eugene,
OR 97440-0972, 541-687-2134.
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA
91311, 800-328-6942 (Formerly: Centinela Hospital Airport Toxicology
Laboratory).
Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane,
WA 99204, 509-755-8991 / 800-541-7897x7.
Physicians Reference Laboratory, 7800 West 110th St., Overland Park, KS
66210, 913-339-0372 / 800-821-3627.
Quest Diagnostics Incorporated, 3175 Presidential Dr., Atlanta, GA
30340, 770-452-1590 / 800-729-6432 (Formerly: SmithKline Beecham
Clinical Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 4770 Regent Blvd., Irving, TX 75063,
800-824-6152 (Moved from the Dallas location on 03/31/01; Formerly:
SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science
Laboratories).
Quest Diagnostics Incorporated, 4230 South Burnham Ave., Suite 250, Las
Vegas, NV 89119-5412, 702-733-7866 / 800-433-2750, (Formerly:
Associated Pathologists Laboratories, Inc.).
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403,
610-631-4600 / 877-642-2216, (Formerly: SmithKline Beecham Clinical
Laboratories; SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 506 E. State Pkwy., Schaumburg, IL
60173, 800-669-6995 / 847-885-2010, (Formerly: SmithKline Beecham
Clinical Laboratories; International Toxicology Laboratories).
Quest Diagnostics Incorporated, 7600 Tyrone Ave., Van Nuys, CA 91405,
818-989-2520 / 800-877-2520, (Formerly: SmithKline Beecham Clinical
Laboratories).
Scientific Testing Laboratories, Inc., 450 Southlake Blvd., Richmond,
VA 23236, 804-378-9130.
Sciteck Clinical Laboratories, Inc., 317 Rutledge Road, Fletcher, NC
28732, 828-650-0409.
S.E.D. Medical Laboratories, 5601 Office Blvd., Albuquerque, NM 87109,
505-727-6300 / 800-999-5227.
South Bend Medical Foundation, Inc., 530 N. Lafayette Blvd., South
Bend, IN 46601, 574-234-4176 x276.
Southwest Laboratories, 4645 E. Cotton Center Boulevard, Suite 177,
Phoenix, AZ 85040, 602-438-8507 / 800-279-0027.
Sparrow Health System, Toxicology Testing Center, St. Lawrence Campus,
1210 W. Saginaw, Lansing, MI 48915, 517-364-7400, (Formerly: St.
Lawrence Hospital & Healthcare System).
St. Anthony Hospital Toxicology Laboratory, 1000 N. Lee St., Oklahoma
City, OK 73101, 405-272-7052.
Toxicology & Drug Monitoring Laboratory, University of Missouri
Hospital & Clinics, 301 Business Loop 70 West, Suite 208, Columbia, MO
65203, 573-882-1273.
Toxicology Testing Service, Inc., 5426 N.W. 79th Ave., Miami, FL 33166,
305-593-2260.
US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St.,
Fort George G. Meade, MD 20755-5235, 301-677-7085.
*The Standards Council of Canada (SCC) voted to end its
Laboratory Accreditation Program for Substance Abuse (LAPSA)
effective May 12, 1998. Laboratories certified through that program
were accredited to conduct forensic urine drug testing as required
by U.S. Department of Transportation (DOT) regulations. As of that
date, the certification of those accredited Canadian laboratories
will continue under DOT authority. The responsibility for conducting
quarterly performance testing plus periodic on-site inspections of
those LAPSA-accredited laboratories was transferred to the U.S. HHS,
with the HHS' NLCP contractor continuing to have an active role in
the performance testing and laboratory inspection processes. Other
[[Page 45735]]
Canadian laboratories wishing to be considered for the NLCP may
apply directly to the NLCP contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to be qualified, HHS will
recommend that DOT certify the laboratory (Federal Register, July
16, 1996) as meeting the minimum standards of the Mandatory
Guidelines published in the Federal Register on April 13, 2004 (69
FR 19644). After receiving DOT certification, the laboratory will be
included in the monthly list of HHS-certified laboratories and
participate in the NLCP certification maintenance program.
Anna Marsh,
Executive Officer, SAMHSA.
[FR Doc. 05-15693 Filed 8-5-05; 8:45 am]
BILLING CODE 4160-20-P
